DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Shemaroo Entertainment Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 1 hr ago·9 Oct 2026, 10:20 am

Shemaroo Entertainment

Shemaroo Entertainment Limited has submitted a compliance certificate to the stock exchanges. This document confirms that the company has fulfilled its regulatory obligations under the SEBI (Depositories and Participants) Regulations, 2018, for the quarter that ended on September 30, 2026.

For investors, this filing is a routine administrative update. It serves as a formal confirmation that the company is adhering to the rules governing its shareholding and depository structures. While this news does not typically signal a significant shift in the company's business performance, it ensures transparency and maintains the company's compliance record with market regulators.

Investors should monitor the company's future earnings reports to gauge its operational progress. This regulatory filing, however, does not directly impact the stock's price movement at this time.